Diabetes and impaired glucose tolerance: a review of the epidemiological and trial evidence for their role in cardiovascular risk.
People with diabetes mellitus are at increased risk of cardiovascular disease (CVD). There is a higher prevalence of recognized risk factors, such as hypertension and abnormal blood lipids, in the diabetic population and this may account for some of the increase in risk. However, the epidemiological...
Main Authors: | Bowman, L, Armitage, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2002
|
Similar Items
-
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
by: Califf, R, et al.
Published: (2008) -
People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
by: Califf, R, et al.
Published: (2003) -
Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
by: Sharma, A, et al.
Published: (2016) -
Cardiovascular outcomes among participants with diabetes in the recent large statin trials.
by: Armitage, J, et al.
Published: (2004) -
Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
by: Anke Tönjes, et al.
Published: (2010-01-01)